Feedback / Questions
zilebesiran (ALN-AGT) - Alnylam, Roche
http://clinicaltrials.gov/ct2/show/NCT06675565
Aug 27, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next